logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Bevacizumab/cabozantinib/sunitinibVarious toxicities: 4 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1865卷 / 1期
关键词:
D O I:
10.1007/s40278-021-99402-3
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:114 / 114
相关论文
共 50 条
  • [41] Bevacizumab/nicorandilVarious toxicities: 4 case reports
    Reactions Weekly, 2018, 1729 (1) : 52 - 52
  • [42] Bevacizumab/irinotecanVarious toxicities: 4 case reports
    Reactions Weekly, 2016, 1612 (1) : 36 - 36
  • [43] Bevacizumab/capecitabineVarious toxicities: 4 case reports
    Reactions Weekly, 2018, 1733 (1) : 83 - 83
  • [44] Bevacizumab/temozolomideVarious toxicities: 4 case reports
    Reactions Weekly, 2017, 1660 (1) : 83 - 83
  • [45] Pazopanib/regorafenib/sunitinibVarious toxicities: 2 case reports
    Reactions Weekly, 2019, 1771 (1) : 248 - 248
  • [46] Pazopanib/sorafenib/sunitinibVarious toxicities: 6 case reports
    Reactions Weekly, 2016, 1583 (1) : 861 - 861
  • [47] Axitinib/pazopanib/sunitinibVarious toxicities: 12 case reports
    Reactions Weekly, 2019, 1755 (1) : 55 - 55
  • [48] Clarithromycin/pazopanib/sunitinibVarious toxicities: 2 case reports
    Reactions Weekly, 2022, 1896 (1) : 134 - 134
  • [49] Everolimus/octreotide/sunitinibVarious toxicities: 6 case reports
    Reactions Weekly, 2017, 1649 (1) : 118 - 118
  • [50] Bevacizumab/carboplatin/paclitaxelVarious toxicities: 4 case reports
    Reactions Weekly, 2018, 1691 (1) : 66 - 66
← 12345 →